{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T02:21:49Z","timestamp":1784514109398,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Porphyrien werden durch Enzymdefekte der H\u00e4mbiosynthese hervorgerufen und anhand spezifischer biochemischer Muster von Porphyrinen und deren Vorl\u00e4ufern in Urin, Stuhl und Blut diagnostiziert. Das jeweilige Muster der akkumulierten Porphyrine, Vorl\u00e4ufer und Derivate ist verbunden mit der klinischen Auspr\u00e4gung, die abdominale, neurologische, psychiatrische, endokrine, kardiovaskul\u00e4re Symptome, Leberschaden und\/oder Lichtempfindlichkeit der Haut umfassen kann. Klinisch werden akute und nichtakute Porphyrien unterschieden. Bei symptomatischen (klinisch aktiven), akuten hepatischen Porphyrien \u2013\u00a0hierzu geh\u00f6ren akute intermittierende Porphyrie, Porphyria variegata, heredit\u00e4re Koproporphyrie und Doss-Porphyrie\u00a0\u2013 kommt es aufgrund einer Regulationsst\u00f6rung zur Kumulation der Porphyrinvorl\u00e4ufer 5\u2011Aminol\u00e4vulins\u00e4ure und Porphobilinogen. Bei den nichtakuten Formen \u2013\u00a0u.\u202fa. Porphyria cutanea tarda, erythropoetische und X\u2011chromosomale Protoporphyrie sowie kongenitale erythropoetische Porphyrie\u00a0\u2013 f\u00fchren akkumulierte Porphyrine zu Lichtempfindlichkeit (Fotodermatose) und mitunter auch zu schweren Lebersch\u00e4den. Zur Therapie der Porphyrien stehen sowohl bew\u00e4hrte und sichere als auch innovative Optionen zur Verf\u00fcgung.<\/jats:p>","DOI":"10.1007\/s00108-021-01066-1","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T12:02:42Z","timestamp":1624968162000},"page":"937-951","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Porphyrien","Porphyria"],"prefix":"10.1007","volume":"62","author":[{"given":"Ulrich","family":"St\u00f6lzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilja","family":"Kubisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"1066_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1053\/j.gastro.2019.04.050","volume":"157","author":"U St\u00f6lzel","year":"2019","unstructured":"St\u00f6lzel\u00a0U, Doss\u00a0MO, Schuppan\u00a0D (2019) Clinical guide and update on porphyrias. Gastroenterology 157:365\u2013381","journal-title":"Gastroenterology"},{"key":"1066_CR2","first-page":"1975","volume":"108","author":"M Doss","year":"1983","unstructured":"Doss\u00a0M (1983) Notate zur Porphyrie. Dtsch Med Wochenschr 108:1975\u20131979","journal-title":"Dtsch Med Wochenschr"},{"key":"1066_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c120006","author":"HL Bonkovsky","year":"2013","unstructured":"Bonkovsky\u00a0HL, Guo\u00a0J\u2011T, Hou\u00a0W, Li\u00a0T, Narang\u00a0T, Thapar\u00a0M (2013) Porphyrin and heme metabolism and the porphyrias. Compr Physiol. https:\/\/doi.org\/10.1002\/cphy.c120006","journal-title":"Compr Physiol"},{"key":"1066_CR4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1073\/pnas.53.4.841","volume":"53","author":"DP Tschudy","year":"1965","unstructured":"Tschudy\u00a0DP, Perlroth\u00a0MG, Marver\u00a0HS, Collins\u00a0A, Hunter\u00a0G, Rechcigl\u00a0M (1965) Acute intermittent porphyria: the first \u201coverproduction disease\u201d localized to a specific enzyme. Proc Natl Acad Sci U S\u00a0A 53:841\u2013847","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1066_CR5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1056\/NEJMra1608634","volume":"377","author":"DM Bissell","year":"2017","unstructured":"Bissell\u00a0DM, Anderson\u00a0KE, Bonkovsky\u00a0HL (2017) Porphyria. N\u00a0Engl J Med 377:862\u2013872","journal-title":"N Engl J Med"},{"key":"1066_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ymgme.2019.04.008","volume":"128","author":"JD Phillips","year":"2019","unstructured":"Phillips\u00a0JD (2019) Heme biosynthesis and the porphyrias. Mol Genet Metab 128:164\u2013177","journal-title":"Mol Genet Metab"},{"key":"1066_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/archderm.139.3.309","volume":"139","author":"U St\u00f6lzel","year":"2003","unstructured":"St\u00f6lzel\u00a0U, K\u00f6stler\u00a0E, Schuppan\u00a0D, Richter\u00a0M, Wollina\u00a0U, Doss\u00a0MO, Wittekind\u00a0C, Tannapfel\u00a0A (2003) Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda. Arch Dermatol 139:309\u2013313","journal-title":"Arch Dermatol"},{"key":"1066_CR8","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1002\/hep.1840210604","volume":"21","author":"U St\u00f6lzel","year":"1995","unstructured":"St\u00f6lzel\u00a0U, K\u00f6stler\u00a0E, Koszka\u00a0C, St\u00f6ffler-Meilicke\u00a0M, Schuppan\u00a0D, Somasundaram\u00a0R, Doss\u00a0MO, Habermehl\u00a0KO, Riecken\u00a0EO (1995) Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 21:1500\u20131503","journal-title":"Hepatology"},{"key":"1066_CR9","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/hep.1840160603","volume":"16","author":"S Fargion","year":"1992","unstructured":"Fargion\u00a0S, Piperno\u00a0A, Cappellini\u00a0MD, Sampietro\u00a0M, Fracanzani\u00a0AL, Romano\u00a0R, Caldarelli\u00a0R, Marcelli\u00a0R, Vecchi\u00a0L, Fiorelli\u00a0G (1992) Hepatitis C virus and porphyria cutanea tarda: evidence of a\u00a0strong association. Hepatology 16:1322\u20131326","journal-title":"Hepatology"},{"key":"1066_CR10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ajhg.2008.08.003","volume":"83","author":"SD Whatley","year":"2008","unstructured":"Whatley\u00a0SD, Ducamp\u00a0S, Gouya\u00a0L et al (2008) C\u2011terminal deletions in the ALAS2 gene lead to gain of function and cause X\u2011linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet 83:408\u2013414","journal-title":"Am J Hum Genet"},{"key":"1066_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30936","author":"L Gouya","year":"2019","unstructured":"Gouya\u00a0L, Ventura\u00a0P, Balwani\u00a0M et\u00a0al (2019) EXPLORE: a prospective, multinational, natural history study of patients with acute hepatic porphyria with recurrent attacks. Hepatology. https:\/\/doi.org\/10.1002\/hep.30936","journal-title":"Hepatology"},{"key":"1066_CR12","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1182\/blood.2020006037","volume":"136","author":"J-M Blouin","year":"2020","unstructured":"Blouin\u00a0J\u2011M, Ged\u00a0C, Lalanne\u00a0M et al (2020) Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria. Blood 136:2457\u20132468","journal-title":"Blood"},{"key":"1066_CR13","volume-title":"Physician\u2019s guide to the diagnosis, treatment, and follow-up of inherited metabolic diseases","author":"B Nenad","year":"2021","unstructured":"Nenad\u00a0B, Blau\u00a0N, Dionisi Vici\u00a0C, Ferreira\u00a0CR, Vianey-Saban\u00a0C, van Karnebeek\u00a0CDM (2021) Physician\u2019s guide to the diagnosis, treatment, and follow-up of inherited metabolic diseases, 2.\u00a0Aufl. Springer, Cham","edition":"2"},{"key":"1066_CR14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/BF01481493","volume":"57","author":"M Doss","year":"1979","unstructured":"Doss\u00a0M, von Tiepermann\u00a0R, Schneider\u00a0J, Schmid\u00a0H (1979) New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation. Klin Wochenschr 57:1123\u20131127","journal-title":"Klin Wochenschr"},{"key":"1066_CR15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.cell.2005.06.040","volume":"122","author":"C Handschin","year":"2005","unstructured":"Handschin\u00a0C, Lin\u00a0J, Rhee\u00a0J, Peyer\u00a0A\u2011K, Chin\u00a0S, Wu\u00a0P\u2011H, Meyer\u00a0UA, Spiegelman\u00a0BM (2005) Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell 122:505\u2013515","journal-title":"Cell"},{"key":"1066_CR16","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1073\/pnas.68.11.2725","volume":"68","author":"HL Bonkowsky","year":"1971","unstructured":"Bonkowsky\u00a0HL, Tschudy\u00a0DP, Collins\u00a0A, Doherty\u00a0J, Bossenmaier\u00a0I, Cardinal\u00a0R, Watson\u00a0CJ (1971) Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad Sci U S\u00a0A 68:2725\u20132729","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1066_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10545-010-9272-6","volume":"34","author":"JK Dowman","year":"2011","unstructured":"Dowman\u00a0JK, Gunson\u00a0BK, Mirza\u00a0DF, Badminton\u00a0MN, Newsome\u00a0PN (2011) UK experience of liver transplantation for erythropoietic protoporphyria. J\u00a0Inherit Metab Dis 34:539\u2013545","journal-title":"J Inherit Metab Dis"},{"key":"1066_CR18","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa1913147","volume":"382","author":"M Balwani","year":"2020","unstructured":"Balwani\u00a0M, Sardh\u00a0E, Ventura\u00a0P et\u00a0al (2020) Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria. N\u00a0Engl J Med 382:2289\u20132301","journal-title":"N Engl J Med"},{"key":"1066_CR19","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1055\/a-1204-0583","volume":"58","author":"U St\u00f6lzel","year":"2020","unstructured":"St\u00f6lzel\u00a0U (2020) RNAi Therapie mit Givosiran f\u00fcr Akut Intermittierende Porphyrie (Phase 3 Studie). Z\u00a0Gastroenterol 58:785\u2013785","journal-title":"Z Gastroenterol"},{"key":"1066_CR20","first-page":"762","volume":"112","author":"V Kordac","year":"1973","unstructured":"Kordac\u00a0V, Semr\u00e1dov\u00e1\u00a0M (1973) Therapy of patients with porphyria cutanea tarda with antimalarials. Cas Lek Cesk 112:762\u2013765","journal-title":"Cas Lek Cesk"},{"key":"1066_CR21","first-page":"253","volume":"14","author":"H Ippen","year":"1977","unstructured":"Ippen\u00a0H (1977) Treatment of porphyria cutanea tarda by phlebotomy. Semin Hematol 14:253\u2013259","journal-title":"Semin Hematol"},{"key":"1066_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1056\/NEJMoa1411481","volume":"373","author":"JG Langendonk","year":"2015","unstructured":"Langendonk\u00a0JG, Balwani\u00a0M, Anderson\u00a0KE et\u00a0al (2015) Afamelanotide for erythropoietic protoporphyria. N\u00a0Engl J Med 373:48\u201359","journal-title":"N Engl J Med"},{"key":"1066_CR23","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/bjh.13612","volume":"173","author":"C Landefeld","year":"2016","unstructured":"Landefeld\u00a0C, Kentouche\u00a0K, Gruhn\u00a0B, Stauch\u00a0T, R\u00f6\u00dfler\u00a0S, Schuppan\u00a0D, Whatley\u00a0SD, Beck\u00a0JF, St\u00f6lzel\u00a0U (2016) X\u2011linked protoporphyria: iron supplementation improves protoporphyrin overload, liver damage and anaemia. Br J Haematol 173:482\u2013484","journal-title":"Br J Haematol"},{"key":"1066_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10545-017-0017-7","volume":"40","author":"J Barman-Aksoezen","year":"2017","unstructured":"Barman-Aksoezen\u00a0J, Girelli\u00a0D, Aurizi\u00a0C, Schneider-Yin\u00a0X, Campostrini\u00a0N, Barbieri\u00a0L, Minder\u00a0EI, Biolcati\u00a0G (2017) Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity. J\u00a0Inherit Metab Dis 40:433\u2013441","journal-title":"J Inherit Metab Dis"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01066-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-021-01066-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01066-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T07:04:12Z","timestamp":1629875052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-021-01066-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1066"],"URL":"https:\/\/doi.org\/10.1007\/s00108-021-01066-1","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"19 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>U.\u00a0St\u00f6lzel<\/b>: A.\u00a0Finanzielle Interessen: Honorar f\u00fcr Vortr\u00e4ge: Alnylam Pharma. \u2013\u00a0Berater und Schulungsreferent: Alnylam Pharma.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Leiter, Porphyriezentrum, Klinikum Chemnitz | Mitgliedschaft: S\u00e4chsische Akademie f\u00fcr \u00e4rztliche Fort- und Weiterbildung. <b>T.\u00a0Stauch<\/b>: A.\u00a0Finanzielle Interessen: Kostenerstattung: Fa. Alnylam. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: klinischer Chemiker, MVZ Labor PD Dr. med. Volkmann und Kollegen GbR, Karlsruhe | Mitgliedschaften: DGKL, GDCh.<b> I.\u00a0Kubisch<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung durch Alnylam.\u00a0\u2013 Honorar f\u00fcr Beitr\u00e4ge und Vortr\u00e4ge: Alnylam. \u2013\u00a0Berater: Alnylam.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: angestellter Oberarzt, Klinikum Chemnitz | Mitgliedschaft: DGVS.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}